Searchable abstracts of presentations at key conferences in endocrinology

ea0065p77 | Adrenal and Cardiovascular | SFEBES2019

Impacts and quality of life for people with adrenal insufficiency using Medical Detection Dogs before and after initiation of continuous subcutaneous hydrocortisone infusion (CSHI)

Yeoh Phillip

Use of medical detection dog to improve hypoglycaemia awareness has been documented. However the data remain limited for people with adrenal insufficiency. We collected data retrospectively and prospectively on the episodes of low cortisol events initiated by medical detection dog and quality of life of 3 people with adrenal insufficiency before and started on continuous subcutaneous hydrocortisone infusion (CSHI) to correlate it with our Addison’s Quality of Life scores....

ea0056n4.3 | (1) | ECE2018

Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance testing with two different doses (0.15 vs 0.10 U/kg)

Yeoh Phillip

The Insulin Tolerance Test (ITT) is the gold standard test to assess growth hormone (GH) and ACTH reserve. This dynamic test induces hypoglycaemia and is commonly performed by endocrine nurses using different insulin doses -commonly 0.15 U or 0.10 U/kg. As part of a quality and safety improvement initiative we conducted a retrospective study to address several questions relating to ITT insulin dose. ITT results (n=148) were retrieved from two large endocrine testing c...

ea0065p59 | Adrenal and Cardiovascular | SFEBES2019

Real life experience of 8 people with adrenal insufficiency using subcutaneous hydrocortisone infusion in continuous and pulsatile regimens recruited through hydrocortisone pump support group

Yeoh Phillip , Kenworthy Jenn

Subcutaneous hydrocortisone (HC) infusion using continuous (CSHI) and pulsatile (PSHI) regimes are treatment options for adrenal insufficiency. It is an off-labelled treatment in UK for patients with adrenal insufficiency (AI). We surveyed 8 cohorts via Cortisol Pump UK support group in Facebook to capture their data in the following area: Quality of Life AddiQoL scores 24 h infusion doses & type of...

ea0070aep24 | Adrenal and Cardiovascular Endocrinology | ECE2020

Real life experience of 8 people with adrenal insufficiency using subcutaneous hydrocortisone infusion in continuous and pulsatile regimens recruited through hydrocortisone pump support group

Yeoh Phillip , Kenworthy Jennifer

Real life experience of 8 people with adrenal insufficiency using subcutaneous hydrocortisone infusion in continuous and pulsatile regimens recruited through hydrocortisone pump support groupBackground: Subcutaneous hydrocortisone (HC) infusion using continuous (CSHI) and pulsatile (PSHI) regimes are treatment options for adrenal insufficiency. It is an off-labelled treatment in UK for patients with adrenal insufficiency (AI).Both ...

ea0056p60 | Adrenal cortex (to include Cushing's) | ECE2018

Expert patients are better prepared to survive adrenal crisis than most – but still lack training in injection method

White Katherine , Yeoh Phillip

We examined online questionnaire responses received Dec 2017 – Jan 2018 from a sample of well-informed adrenal patients belonging to the Addison’s Disease Self-Help Group (N=374). ADSHG members reported levels of preparedness to self-manage during adrenal emergencies that were strikingly higher than any UK clinic survey.• 88% reported wearing medical jewellery• 80% had an in-date injection kit with them at the t...

ea0050p314 | Nursing Practice | SFEBES2017

UK experience with continuous subcutaneous hydrocortisone infusion in patients with adrenal insufficiency

Yeoh Phillip , Khoo Bernard , Carroll Paul

Continouos subcutaneous hydrocortisone infusion (CSHI) is a novo treatment for adrenal insufficieny. This treatment aim to mimic body circadian rhythm by providing a continouos slow infusion subcutanously.We summarise our experience with 5 patients: 1 with primary adrenal insufficiency and 4 with secondary adrenal insufficiency. There are 1 male and 4 females with a mean age 31. All these patients were self referred and have tried ...

ea0050p314 | Nursing Practice | SFEBES2017

UK experience with continuous subcutaneous hydrocortisone infusion in patients with adrenal insufficiency

Yeoh Phillip , Khoo Bernard , Carroll Paul

Continouos subcutaneous hydrocortisone infusion (CSHI) is a novo treatment for adrenal insufficieny. This treatment aim to mimic body circadian rhythm by providing a continouos slow infusion subcutanously.We summarise our experience with 5 patients: 1 with primary adrenal insufficiency and 4 with secondary adrenal insufficiency. There are 1 male and 4 females with a mean age 31. All these patients were self referred and have tried ...

ea0065p340 | Nursing practice | SFEBES2019

A simple tool to assess the self-care management knowledge and skill needs of people with adrenal insufficiency (AI) before their adrenal education

Yeoh Phillip , Peti Noumba , Chan Susan

We adapted holistic needs assessment tool used in oncology setting to create a simple tool to assess the learning need of people with adrenal insufficiency. This simple tool consists of 17 items and it allows endocrine nurse educators to obtain a quick assessment on the self-care management knowledge and skill of people with adrenal insufficiency before embarking on adrenal education.The tool 17 items are:Understanding of adrenal i...

ea0081ep3 | Adrenal and Cardiovascular Endocrinology | ECE2022

Impact of adrenocortical carcinoma and associated adrenal insufficiency on patient wellbeing – a systematic review

Yeoh Phillip , Czuber-Dochan Wladyslawa , Aylwin Simon , Sturt Jackie

Context: Adrenocortical carcinoma is a rare cancer with an annual incidence of 0.7-2 cases per million population and 5-year survival of 31.2%. Adrenal insufficiency is a common and life shortening complication of ACC and little is understood about how it impacts on patients.Objective: To understand patients’ experience of the condition, its treatment, care process, impact of AI on ACC wellbeing, self-care needs and support.De...

ea0056ep16 | Adrenal and Neuroendocrine Tumours | ECE2018

Patient experiences with continouous subcutaneous hydrocortisone infusion (CSHI)

Yeoh Phillip , Khoo Bernard , Carroll Paul , Aylwin Simon

We recently reported the impact of continous s.c. hydrocortisone infusion (CSHI) on weight, patient AddiQoL scores and healthcare cost savings on five patients. This poster is to follow up on all our patients experiences since started on the CSHI as well as qualitative feedback on the impact on their lives.This poster also gathered key points on how these patients managed their adrenal crisis....